Tag archive for ‘Jerusalem Brokerage’
Koby Yeshayahou On Wednesday, December 17th, 2014

Brokerage Upgrades Teva Recommendation following Copaxone Dosage Change

– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target price of More...

Wordpress site Developed by Fixing WordPress Problems